Celltrion said on Tuesday that it won a patent invalidation lawsuit against Roche (Genentech) in Taiwan for the Rheumatoid Arthritis (RA) indication of Truxima, a biosimilar of the original drug Rituxan (ingredient name: rituximab).Celltrion had previously invalidated the related patent in Korea in
SillaJen said it inked a deal with Basilea Pharmaceutica, a Switzerland-based biopharmaceutical company, to license in the latter's BAL0891, an anticancer drug candidate.Under the agreement, Basilea will receive an upfront payment of $14 million and can receive up to $335 million for milestones acco
Drugmakers are gearing up to race in the development of a denosumab biosimilar to treat various bone diseases. Sandoz, a subsidiary of Novartis handling off-patent medicines, said on Monday that it confirmed positive results from a study of a proposed biosimilar denosumab (original brands: Prolia, X
The country added 19,407 new Covid-19 infections, including 289 cases from abroad, bringing the total caseload to 24,413,873, according to the Korea Disease Control and Prevention Agency (KDCA). The figure is the lowest since July 11, when the country reported 12,672 cases.The nation also reported 3
Domestic industry executives are watching closely when the regulator will release the result of their review of Envlo Tab. (ingredient: enavogliflozin, development name: DWP16001), a new diabetes treatment drug under development by Daewoong Pharmaceutical.The Ministry of Food and Drug Safety publish
LegoChem Biosciences has proved LCB14's competitiveness, a human epidermal growth factor 2 (HER2)-ADC candidate, through positive results from its phase 1a and 1b trials in patients with HER2-positive breast cancer, amid growing anticipations for antibody-drug conjugates (ADCs), an analyst said.The
Genomictree said that it has started selling Earlytect, its colorectal cancer screening service, through Malaysia's largest telemedicine platform, DoctorOnCall.Genomictree plans to expand the market share by diversifying sales channels, establishing a telemedicine business model through DoctorOnCall
After the Korean health authorities floated the possibility of lifting the mandatory mask wearing amid the abating of new Covid-19 cases, an expert said infants and toddlers should be the first group to remove masks.Jung Jae-hun, a professor of preventive medicine at Gachon University College of Med
Takeda Korea said on Monday that its PARP inhibitor, Zejula (niraparib), has confirmed the continuous and long-term progression-free survival (PFS) and disease resolution in the primary maintenance treatment of newly diagnosed patients with progressive ovarian cancer.The median follow-up period was
ABL Bio will receive a short-term milestone of $20 million (27.8 billion won) from Sanofi.ABL Bio said in a public notice last Thursday that it would get $20 million in technical fees from Sanofi. The company explained that it was a milestone upon the completion of the non-clinical toxicity test (GL
“Sometimes, we find it difficult to explain some parts even with pictures from anatomy textbooks. For example, in which direction the blood flows in the heart or how the aorta goes up and down. However, by using virtual reality (VR) contents, we can confirm these things more easily, and the body vie
Wells Bio said Monday that "careGENE HPV detection kit-M," an independently developed human papillomavirus (HPV) molecular diagnosis kit, has obtained domestic permission.The in vitro diagnostic device helps diagnose HPV infection by detecting DNA extracted from women's cervical liquid cell samples
Celltrion said that the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Vegzelma, a biosimilar referencing Avastin (ingredient: bevacizumab), to treat various cancers.The company received full label approval for all of Avastin's indications, including metastatic colore
Korea's top quarantine advisor said it was time to convert the Covid-19 emergency response system into a daily response one.“We need to start discussing the transition from the current Covid-19 emergency response system to the daily Covid-19 response system,” said Jung Ki-suck, head of the National
A research team at Kyung Hee University Medical Center has discovered that tumor mutation burden (TMB) is a biomarker that can predict the targeted therapy response in epidermal growth factor receptor (EGFR)-positive lung cancer patients.The team, led by Professors Lee Seung-hyeun of the Department
The quarantine authorities will expand the use of SKYCovione, the first homegrown Covid-19 vaccine developed by SK Bioscience, to provide third and fourth shots.The Central Disaster and Safety Countermeasures Headquarters (CDCSH) announced the “additional vaccination plan for SKYCovione” in a briefi
Yuhan Corp. has recently acquired AtoGen, a subsidiary of the cosmetics company, Tonymoly, attracting the industry’s attention to its background. Yuhan said it would expand its microbiome business by acquiring AtoGen, which researches and develops microbiome treatments.Yuhan announced its equity acq
Prestige BioPharma said Thursday it has voluntarily withdrawn its European Medicines Agency (EMA) application for the re-examination of approving HD201 (brand name: Tuznue), a biosimilar referencing Herceptin to treat breast cancer and metastatic gastric cancer.The withdrawal comes after the company
Korea’s university hospitals are winning global recognition for their expertise in five clinical fields -- endocrinology, orthopedics, pulmonology, urology, and neurology, according to a recent survey.U.S. magazine Newsweek has announced World’s Best Specialized Hospitals 2023 jointly with a global
GE Healthcare Korea said UGAP (Ultrasound-Guided Attenuation Parameter), which can quantitatively scan for hepatic steatosis of non-alcoholic fatty liver disease (NAFLD) using B-mode ultrasound attenuation coefficient, was recognized by the government as newmedical technology.UGAP makes quantitative